Newsroom

Takeda Corporate Information

To learn about our parent company, Takeda Pharmaceutical Company Limited, please visit http://www.takeda.com/

Media Inquiries

Please contact us at US.corporatecommunications@takeda.com or (224) 554-5499.

Recent News Releases

November 6, 2019 11/6/2019

Takeda to Highlight Expanded Portfolio of Products Across Oncology and Hematology at 61^st American Society of Hematology (ASH) Annual Meeting

October 28, 2019 10/28/2019

First-Ever U.S. Pivotal Phase 3 Clinical Study in Eosinophilic Esophagitis (EoE) Completes: Takeda’s Investigational Therapy Meets Co-Primary & Key Secondary Efficacy Endpoints

October 10, 2019 10/10/2019

Working Mother Names Takeda as One of the 2019 100 Best Companies

September 25, 2019 9/25/2019

First Head-to-Head Biologic Study in Ulcerative Colitis Published in The New England Journal of Medicine Highlights Benefit of Vedolizumab vs. Adalimumab

September 24, 2019 9/24/2019

Takeda Announces NATPARA^® Special Use Program in the US

SEE ALL NEWS AND RELEASES >